![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0002-8914-4267
References
- Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, et al. 2005. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 14:2929–2935.
- Christacos NC, Quade BJ, Dal Cin P, Morton CC. 2006. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes, Chromosomes & Cancer 45:304–312.
- Conconi D, Redaelli S, Lissoni A, Cilibrasi C, Perego P, Gautiero E, et al. 2021. Genomic and epigenomic profile of uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) revealed similarities and differences with leiomyomas and leiomyosarcomas. International Journal of Molecular Sciences 22:1580–1595.
- Cramer SF, Mann L, Calianese E, Daley J, Williamson K. 2009. Association of seedling myomas with myometrial hyperplasia. Human Pathology 40:218–225.
- Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, et al. 2009. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiology, Biomarkers & Prevention 18:1448–1456.
- Gadducci A. 2011. Prognostic factors in uterine sarcoma. Best Practice & Research. Clinical Obstetrics & Gynaecology 25:783–795.
- Garcia C, Kubat JS, Fulton RS, Anthony AT, Combs M, Powell CB, et al. 2015. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort. International Journal of Gynecological Cancer 25:622–628.
- Giuliani E, As-Sanie S, Marsh EE. 2020. Epidemiology and management of uterine fibroids. International Journal of Gynaecology and Obstetrics 149:3–9.
- Giuntoli RL, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, et al. 2003. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecologic Oncology 89:460–469.
- Giuntoli RL, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. 2nd., 2007. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. The Journal of Reproductive Medicine 52:1001–1010.
- Hodge JC, Pearce KE, Clayton AC, Taran FA, Stewart EA. 2014. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. American Journal of Obstetrics and Gynecology 210:572.e1–572.e7. [Epub 2014 Jan 8].
- Hodge JC, Morton CC. 2007. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Human Molecular Genetics 16:R7–R13.
- Johnatty SE, Stewart CJR, Smith D, Nguyen A, O' Dwyer J, O'Mara TA, et al. 2020. Co-existence of leiomyomas, adenomyosis and endometriosis in women with endometrial cancer. Scientific Reports, 10:3621.
- Kim L, Kim JA, Kim S. 2014. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiology and Health 36:e2014008.
- Leibsohn S, d'Ablaing G, Mishell DR, Schlaerth JB. 1990. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. American Journal of Obstetrics and Gynecology 162:968–974. discussion 974.
- Quade BJ, Wang T-Y, Sornberger K, Dal Cin P, Mutter GL, Morton CC, et al. 2004. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes, Chromosomes & Cancer 40:97–108.
- Ricci S, Stone RL, Fader AN. 2017. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies, and the impact of uterine morcellation. Gynecologic Oncology 145:208–216.
- Robboy SJ, Bentley RC, Butnor K, Anderson MC. 2000. Pathology and pathophysiology of uterine smooth-muscle tumors. Environmental Health Perspectives 108:779–784.
- Seagle B-LL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S, et al. 2017. Prognosis and treatment of uterine leiomyosarcoma: a national cancer database study. Gynecologic Oncology 145:61–70.
- Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics 2015. CA: a Cancer Journal for Clinicians 65:5–29.
- Stewart EA, Morton CC. 2006. The genetics of uterine leiomyomata: what clinicians need to know. Obstetrics and Gynecology 107:917–921.
- Taran FA, Weaver AL, Gostout BS, Stewart EA. 2010. Understanding cellular leiomyomas: a case-control study. American Journal of Obstetrics and Gynecology 203:109.e1–109.e6.
- Wise LA, Sponholtz TR, Rosenberg L, Adams-Campbell LL, Kuohung W, LaValley MP, et al. 2016. History of uterine leiomyoma and risk of endometrial cancer in black women. Cancer Causes & Control 27:545–552.